Type / Class
Equity / American Depositary Shares, each representing 1 Ordinary Shares
Shares outstanding
100M
Number of holders
39
Total 13F shares, excl. options
10.3M
Shares change
-536K
Total reported value, excl. options
$23.6M
Value change
-$1.48M
Number of buys
17
Number of sells
-14
Price
$2.29

Significant Holders of Cellectis S.A. - American Depositary Shares, each representing 1 Ordinary Shares (CLLS) as of Q3 2022

42 filings reported holding CLLS - Cellectis S.A. - American Depositary Shares, each representing 1 Ordinary Shares as of Q3 2022.
Cellectis S.A. - American Depositary Shares, each representing 1 Ordinary Shares (CLLS) has 39 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 10.3M shares of 100M outstanding shares and own 10.24% of the company stock.
Largest 10 shareholders include Long Focus Capital Management, LLC (2.68M shares), CREDIT SUISSE AG/ (1.44M shares), PRINCIPAL FINANCIAL GROUP INC (1.34M shares), BAILLIE GIFFORD & CO (789K shares), MILLENNIUM MANAGEMENT LLC (574K shares), Capital International Investors (449K shares), JANE STREET GROUP, LLC (344K shares), BlackRock Inc. (282K shares), D. E. Shaw & Co., Inc. (278K shares), and STATE STREET CORP (262K shares).
This table shows the top 39 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
Investor Option Weight % Change % Value $ * Price $ Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.